-
19 November 2020
COVID-19 must transform the definition of global health security
By Peter Sands, Executive Director
The recent announcements that multiple new coronavirus vaccines are showing strong results provide hope that life will eventually return to normal and the catastrophic death toll will end – good news we all desperately need right now. -
19 November 2020
Why drug-resistant tuberculosis poses a major risk to global health security
By Dr. Eliud Wandwalo, Head of Tuberculosis Department
Drug-resistant tuberculosis (DR-TB) is a form of antimicrobial resistance that is difficult and costly to treat. It is caused by TB bacteria that are resistant to at least one of the first-line existing TB medications, resulting in fewer treatment op... -
29 September 2020
COVID-19 Rapid Tests: A Milestone in Fight Against the Pandemic - By Peter Sands, Executive Director of the Global Fund
-
21 September 2020
COVID-19 is a Turning Point for Infectious Diseases - By Peter Sands, Executive Director of the Global Fund
-
14 September 2020
Fragile Progress in the Fight Against HIV, Tuberculosis and Malaria (in French) With Françoise Vanni, Head of External Relations and Communications at the Global Fund
-
03 September 2020
Conversation with Francoise Vanni (in Italian) With Françoise Vanni, Head of External Relations and Communications at the Global Fund
-
10 August 2020
An Effective Global Response to COVID-19 will Require Unprecedented Levels of Collaboration, Innovation and Money - By Peter Sands, Executive Director of the Global Fund
-
30 July 2020
COVID and the Big Three With Urban Weber, Head of High Impact Asia Department at the Global Fund
-
13 July 2020
The "Huge Amount at Stake" for HIV Progress With Peter Sands, Executive Director of the Global Fund
-
13 July 2020
HIV, Tuberculosis, and Malaria: How can the Impact of COVID-19 be Minimised? - By Peter Sands, Executive Director of the Global Fund